[Hyperthermic intraperitoneal chemotherapy in the German DRG system. Analysis of case cost calculations of a maximum care university]
- PMID: 20552152
- DOI: 10.1007/s00104-010-1927-1
[Hyperthermic intraperitoneal chemotherapy in the German DRG system. Analysis of case cost calculations of a maximum care university]
Abstract
Background: Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) offers patients with peritoneal cancer of various origins the chance of a relevant increase in life expectancy. These cases are very complex from a medical viewpoint and very expensive from an economical aspect. An analysis of case cost calculations was performed to find out whether this procedure can on average be carried out cost-effectively by a maximum care university.
Materials and methods: All cases from 2008 in which HIPEC was carried out were analyzed. The types of main diagnosis, secondary diagnoses, procedures, times from incision to suture and hospital stay were analyzed. On the basis of the case costs the proceeds and marginal returns were calculated from the diagnosis-related groups (DRGs) and additional remuneration when applicable. The causes of positive and negative marginal returns were explained using the InEK cost matrix.
Results: In 18 patients there were 9 different main diagnoses and 7 different "main procedures" (from a surgical perspective the most resource intensive procedures) and a total of 10 different DRGs were identified in the grouping algorithm. With an average of 2 operations (range 1-7) per patient the summed incision-to-suture time was 423 min (170-962 min). The patients stayed on average 6.4 days (1.3-17.6 days) in intensive care. The average case cost was 21,072€ (range 8,657-55,904€) and the proceeds 20,474€ (6,333-37,497€). Each case had on average a debit balance of 598€ (range from 11,843€ profit balance to 18,407€ debit balance) with an assumed base rate of 2,786€. The causes for positive or negative marginal profits were mostly operating times, incision-to-suture times and duration of intensive care.
Conclusions: The proceeds showed on average a deficit of only 3% compared to the costs. The operating times must be decreased by optimization particularly of the preoperative approach. Interventions should be carried out in one stage only and the intraoperative connecting and waiting times should be reduced in order to reduce the incision-to-suture times.
Similar articles
-
Peritonectomy and hyperthermic intraperitoneal chemotherapy: cost analysis and sustainability.Eur J Surg Oncol. 2015 Mar;41(3):386-91. doi: 10.1016/j.ejso.2014.12.004. Epub 2014 Dec 19. Eur J Surg Oncol. 2015. PMID: 25554680
-
Evaluation of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a community setting: A cost-utility analysis of a hospital's initial experience and reflections on the health care system.J Surg Oncol. 2016 Apr;113(5):544-7. doi: 10.1002/jso.24162. Epub 2016 Jan 11. J Surg Oncol. 2016. PMID: 26750613
-
Cost Effectiveness of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Management of Colorectal Peritoneal Carcinomatosis.Ann Surg Oncol. 2018 Aug;25(8):2340-2346. doi: 10.1245/s10434-018-6508-4. Epub 2018 Jun 8. Ann Surg Oncol. 2018. PMID: 29948417
-
[Hyperthermic intraperitoneal chemotherapy at the primary gastrointestinal cancer operation].Ugeskr Laeger. 2017 Mar 20;179(12):V06160454. Ugeskr Laeger. 2017. PMID: 28330549 Review. Danish.
-
Hyperthermic intraperitoneal chemotherapy for the treatment of ovarian cancer: A brief overview of recent results.Crit Rev Oncol Hematol. 2015 Sep;95(3):297-305. doi: 10.1016/j.critrevonc.2015.03.007. Epub 2015 Apr 11. Crit Rev Oncol Hematol. 2015. PMID: 25900072 Review.
Cited by
-
[Is cytoreductive surgery with HIPEC adequately funded?].Chirurgie (Heidelb). 2025 Feb 19. doi: 10.1007/s00104-025-02246-7. Online ahead of print. Chirurgie (Heidelb). 2025. PMID: 39971798 German.
-
Development of a clinical trial to determine whether watchful waiting is an acceptable alternative to surgical repair for patients with oligosymptomatic incisional hernia: study protocol for a randomized controlled trial.Trials. 2012 Feb 7;13:14. doi: 10.1186/1745-6215-13-14. Trials. 2012. PMID: 22314130 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
